Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors

Authors: Kirsten Ludwig, Edison S Tse, Jean YJ Wang

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

The intestinal crypt homeostasis is maintained by a combination of growth factors including Wnt, R-Spondin1, Noggin and the epidermal growth factor (EGF). In human colorectal cancer, the Wnt pathway is constitutively activated through genetic and epigenetic alterations in as many as 11 genes encoding components of this crypt stem-cell maintenance mechanism. Although the proliferation of colon cancer cells does not require Wnt, it is possible that colon cancer cells can still respond to the crypt growth factors in the colonic microenvironment. A number of studies have shown that epithelial cells behave differently in 3-D versus 2-D cultures. Because the 3-D conditions more closely mimic the in vivo environment, we examined the effects of Wnt and other crypt growth factors on colon cancer cell growth in 3-D culture.

Methods

Colon cancer cells were grown in 3-D matrigel supplemented with different combinations of crypt growth factors and colonies were examined for morphology and pathways.

Results

When colon cancer cells were cultured in 3-D with EGF, they grew as round spheroid colonies. However, colon cancer cells also grew as flat, disc-like colonies when cultured with EGF plus Wnt, R-Spondin1 and Noggin. Disc colonies were found to have comparable levels of E-cadherin as the spheroid colonies, but showed decreased E-cadherin at the cell-matrix contact sites. Disc colonies also elaborated F-actin rich protrusions (FRP) at the cell-matrix edge, reminiscent of an invasive phenotype but without the expression of vimentin. These E-cadherin and F-actin alterations were not induced by the four growth factors in 2-D culture. Formation of the disc colonies was inhibited by the knockdown of β-catenin and by protein kinase inhibitors such as gefitinib, imatinib and MK-2206. Furthermore, withdrawal of the crypt growth factors was able to revert the disc colonies to spheroid growth, showing that the invasive phenotype was reversible dependent on the availability of growth factors.

Conclusions

These findings show that colon cancer cells remain responsive to the growth factors in the crypt microenvironment and can be induced to undergo morphological transformation in the more physiologically relevant 3-D culture.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mareel M, Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev. 2003, 83 (2): 337-376.CrossRefPubMed Mareel M, Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev. 2003, 83 (2): 337-376.CrossRefPubMed
2.
go back to reference Gerber B, Krause A, Muller H, Richter D, Reimer T, Makovitzky J, Herrnring C, Jeschke U, Kundt G, Friese K: Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol. 2001, 19 (4): 960-971.PubMed Gerber B, Krause A, Muller H, Richter D, Reimer T, Makovitzky J, Herrnring C, Jeschke U, Kundt G, Friese K: Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol. 2001, 19 (4): 960-971.PubMed
3.
go back to reference Micalizzi DS, Farabaugh SM, Ford HL: Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 2010, 15 (2): 117-134. 10.1007/s10911-010-9178-9.CrossRefPubMedPubMedCentral Micalizzi DS, Farabaugh SM, Ford HL: Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 2010, 15 (2): 117-134. 10.1007/s10911-010-9178-9.CrossRefPubMedPubMedCentral
5.
go back to reference Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA. 2001, 98 (18): 10356-10361. 10.1073/pnas.171610498.CrossRefPubMedPubMedCentral Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R, Kirchner T: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA. 2001, 98 (18): 10356-10361. 10.1073/pnas.171610498.CrossRefPubMedPubMedCentral
6.
go back to reference Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012, 487 (7407): 330-337. 10.1038/nature11252. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012, 487 (7407): 330-337. 10.1038/nature11252.
7.
go back to reference Medema JP, Vermeulen L: Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature. 2011, 474 (7351): 318-326. 10.1038/nature10212.CrossRefPubMed Medema JP, Vermeulen L: Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature. 2011, 474 (7351): 318-326. 10.1038/nature10212.CrossRefPubMed
8.
go back to reference Clevers H: Wnt/beta-catenin signaling in development and disease. Cell. 2006, 127 (3): 469-480. 10.1016/j.cell.2006.10.018.CrossRefPubMed Clevers H: Wnt/beta-catenin signaling in development and disease. Cell. 2006, 127 (3): 469-480. 10.1016/j.cell.2006.10.018.CrossRefPubMed
9.
go back to reference Bowman A, Nusse R: Location, location, location: FoxM1 mediates beta-catenin nuclear translocation and promotes glioma tumorigenesis. Cancer Cell. 2011, 20 (4): 415-416. 10.1016/j.ccr.2011.10.003.CrossRefPubMed Bowman A, Nusse R: Location, location, location: FoxM1 mediates beta-catenin nuclear translocation and promotes glioma tumorigenesis. Cancer Cell. 2011, 20 (4): 415-416. 10.1016/j.ccr.2011.10.003.CrossRefPubMed
10.
go back to reference Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST: Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci USA. 2007, 104 (39): 15418-15423. 10.1073/pnas.0707210104.CrossRefPubMedPubMedCentral Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST: Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci USA. 2007, 104 (39): 15418-15423. 10.1073/pnas.0707210104.CrossRefPubMedPubMedCentral
11.
go back to reference Wei Q, Yokota C, Semenov MV, Doble B, Woodgett J, He X: R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling. J Biol Chem. 2007, 282 (21): 15903-15911. 10.1074/jbc.M701927200.CrossRefPubMed Wei Q, Yokota C, Semenov MV, Doble B, Woodgett J, He X: R-spondin1 is a high affinity ligand for LRP6 and induces LRP6 phosphorylation and beta-catenin signaling. J Biol Chem. 2007, 282 (21): 15903-15911. 10.1074/jbc.M701927200.CrossRefPubMed
12.
go back to reference Zhang HH, Walker F, Kiflemariam S, Whitehead RH, Williams D, Phillips WA, Mikeska T, Dobrovic A, Burgess AW: Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf. Int J Cancer. 2009, 125 (2): 297-307. 10.1002/ijc.24289.CrossRefPubMed Zhang HH, Walker F, Kiflemariam S, Whitehead RH, Williams D, Phillips WA, Mikeska T, Dobrovic A, Burgess AW: Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf. Int J Cancer. 2009, 125 (2): 297-307. 10.1002/ijc.24289.CrossRefPubMed
13.
go back to reference Debnath J, Muthuswamy SK, Brugge JS: Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003, 30 (3): 256-268. 10.1016/S1046-2023(03)00032-X.CrossRefPubMed Debnath J, Muthuswamy SK, Brugge JS: Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 2003, 30 (3): 256-268. 10.1016/S1046-2023(03)00032-X.CrossRefPubMed
14.
go back to reference Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ: Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009, 459 (7244): 262-265. 10.1038/nature07935.CrossRefPubMed Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ: Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009, 459 (7244): 262-265. 10.1038/nature07935.CrossRefPubMed
15.
go back to reference Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology. 2011, 141 (5): 1762-1772. 10.1053/j.gastro.2011.07.050.CrossRefPubMed Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology. 2011, 141 (5): 1762-1772. 10.1053/j.gastro.2011.07.050.CrossRefPubMed
16.
go back to reference Kuntzer J, Eggle D, Lenhof HP, Burtscher H, Klostermann S: The Roche Cancer Genome Database (RCGDB). Hum Mutat. 2010, 31 (4): 407-413. 10.1002/humu.21207.CrossRefPubMed Kuntzer J, Eggle D, Lenhof HP, Burtscher H, Klostermann S: The Roche Cancer Genome Database (RCGDB). Hum Mutat. 2010, 31 (4): 407-413. 10.1002/humu.21207.CrossRefPubMed
17.
go back to reference Nishioka M, Ueno K, Hazama S, Okada T, Sakai K, Suehiro Y, Okayama N, Hirata H, Oka M, Imai K: Possible involvement of Wnt11 in colorectal cancer progression. Mol Carcinog. 2013, 52 (3): 207-217. 10.1002/mc.21845.CrossRefPubMed Nishioka M, Ueno K, Hazama S, Okada T, Sakai K, Suehiro Y, Okayama N, Hirata H, Oka M, Imai K: Possible involvement of Wnt11 in colorectal cancer progression. Mol Carcinog. 2013, 52 (3): 207-217. 10.1002/mc.21845.CrossRefPubMed
18.
go back to reference Planutis K, Planutiene M, Moyer MP, Nguyen AV, Perez CA, Holcombe RF: Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC Cell Biol. 2007, 8: 12-10.1186/1471-2121-8-12.CrossRefPubMedPubMedCentral Planutis K, Planutiene M, Moyer MP, Nguyen AV, Perez CA, Holcombe RF: Regulation of norrin receptor frizzled-4 by Wnt2 in colon-derived cells. BMC Cell Biol. 2007, 8: 12-10.1186/1471-2121-8-12.CrossRefPubMedPubMedCentral
19.
go back to reference Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R, Hinoda Y: Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer. 2009, 101 (8): 1374-1381. 10.1038/sj.bjc.6605307.CrossRefPubMedPubMedCentral Ueno K, Hazama S, Mitomori S, Nishioka M, Suehiro Y, Hirata H, Oka M, Imai K, Dahiya R, Hinoda Y: Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer. 2009, 101 (8): 1374-1381. 10.1038/sj.bjc.6605307.CrossRefPubMedPubMedCentral
20.
go back to reference Feng Y, Dai X, Li X, Wang H, Liu J, Zhang J, Du Y, Xia L: EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Prolif. 2012, 45 (5): 413-419. 10.1111/j.1365-2184.2012.00837.x.CrossRefPubMed Feng Y, Dai X, Li X, Wang H, Liu J, Zhang J, Du Y, Xia L: EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Prolif. 2012, 45 (5): 413-419. 10.1111/j.1365-2184.2012.00837.x.CrossRefPubMed
21.
go back to reference Gao Y, Kitagawa K, Hiramatsu Y, Kikuchi H, Isobe T, Shimada M, Uchida C, Hattori T, Oda T, Nakayama K: Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis. Cancer Res. 2006, 66 (24): 11623-11631. 10.1158/0008-5472.CAN-06-2629.CrossRefPubMed Gao Y, Kitagawa K, Hiramatsu Y, Kikuchi H, Isobe T, Shimada M, Uchida C, Hattori T, Oda T, Nakayama K: Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis. Cancer Res. 2006, 66 (24): 11623-11631. 10.1158/0008-5472.CAN-06-2629.CrossRefPubMed
22.
go back to reference Qi L, Sun B, Liu Z, Li H, Gao J, Leng X: Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci. 2012, 103 (4): 828-835. 10.1111/j.1349-7006.2012.02222.x.CrossRefPubMed Qi L, Sun B, Liu Z, Li H, Gao J, Leng X: Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci. 2012, 103 (4): 828-835. 10.1111/j.1349-7006.2012.02222.x.CrossRefPubMed
23.
go back to reference Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R, Barrow D, Nicholson RI: Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer. 2006, 118 (2): 290-301. 10.1002/ijc.21355.CrossRefPubMed Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi R, Barrow D, Nicholson RI: Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer. 2006, 118 (2): 290-301. 10.1002/ijc.21355.CrossRefPubMed
24.
go back to reference Foroni C, Broggini M, Generali D, Damia G: Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev. 2012, 38 (6): 689-697. 10.1016/j.ctrv.2011.11.001.CrossRefPubMed Foroni C, Broggini M, Generali D, Damia G: Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev. 2012, 38 (6): 689-697. 10.1016/j.ctrv.2011.11.001.CrossRefPubMed
26.
go back to reference Discher DE, Janmey P, Wang YL: Tissue cells feel and respond to the stiffness of their substrate. Science. 2005, 310 (5751): 1139-1143. 10.1126/science.1116995.CrossRefPubMed Discher DE, Janmey P, Wang YL: Tissue cells feel and respond to the stiffness of their substrate. Science. 2005, 310 (5751): 1139-1143. 10.1126/science.1116995.CrossRefPubMed
27.
go back to reference Solon J, Levental I, Sengupta K, Georges PC, Janmey PA: Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J. 2007, 93 (12): 4453-4461. 10.1529/biophysj.106.101386.CrossRefPubMedPubMedCentral Solon J, Levental I, Sengupta K, Georges PC, Janmey PA: Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J. 2007, 93 (12): 4453-4461. 10.1529/biophysj.106.101386.CrossRefPubMedPubMedCentral
28.
go back to reference Levental I, Georges PC, Janmey PA: Soft biological materials and their impact on cell function. Soft Matter. 2007, 3 (3): 299-306. 10.1039/b610522j.CrossRef Levental I, Georges PC, Janmey PA: Soft biological materials and their impact on cell function. Soft Matter. 2007, 3 (3): 299-306. 10.1039/b610522j.CrossRef
29.
go back to reference Schwartz MA: Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol. 2010, 2 (12): a005066-10.1101/cshperspect.a005066.CrossRefPubMedPubMedCentral Schwartz MA: Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol. 2010, 2 (12): a005066-10.1101/cshperspect.a005066.CrossRefPubMedPubMedCentral
30.
31.
go back to reference Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, Matsui S, Friedland S: Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008, 299 (9): 1027-1035. 10.1001/jama.299.9.1027.CrossRefPubMed Soetikno RM, Kaltenbach T, Rouse RV, Park W, Maheshwari A, Sato T, Matsui S, Friedland S: Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008, 299 (9): 1027-1035. 10.1001/jama.299.9.1027.CrossRefPubMed
32.
go back to reference Uronis JM, Herfarth HH, Rubinas TC, Bissahoyo AC, Hanlon K, Threadgill DW: Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage. Cancer Res. 2007, 67 (24): 11594-11600. 10.1158/0008-5472.CAN-07-3242.CrossRefPubMed Uronis JM, Herfarth HH, Rubinas TC, Bissahoyo AC, Hanlon K, Threadgill DW: Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage. Cancer Res. 2007, 67 (24): 11594-11600. 10.1158/0008-5472.CAN-07-3242.CrossRefPubMed
33.
go back to reference Takahashi T, Nosho K, Yamamoto H, Mikami M, Taniguchi H, Miyamoto N, Adachi Y, Itoh F, Imai K, Shinomura Y: Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas. Mod Pathol. 2007, 20 (1): 139-147. 10.1038/modpathol.3800722.CrossRefPubMed Takahashi T, Nosho K, Yamamoto H, Mikami M, Taniguchi H, Miyamoto N, Adachi Y, Itoh F, Imai K, Shinomura Y: Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas. Mod Pathol. 2007, 20 (1): 139-147. 10.1038/modpathol.3800722.CrossRefPubMed
34.
go back to reference Hu T, Li C, Cao Z, Van Raay TJ, Smith JG, Willert K, Solnica-Krezel L, Coffey RJ: Myristoylated Naked2 antagonizes Wnt-beta-catenin activity by degrading Dishevelled-1 at the plasma membrane. J Biol Chem. 2010, 285 (18): 13561-13568. 10.1074/jbc.M109.075945.CrossRefPubMedPubMedCentral Hu T, Li C, Cao Z, Van Raay TJ, Smith JG, Willert K, Solnica-Krezel L, Coffey RJ: Myristoylated Naked2 antagonizes Wnt-beta-catenin activity by degrading Dishevelled-1 at the plasma membrane. J Biol Chem. 2010, 285 (18): 13561-13568. 10.1074/jbc.M109.075945.CrossRefPubMedPubMedCentral
Metadata
Title
Colon cancer cells adopt an invasive phenotype without mesenchymal transition in 3-D but not 2-D culture upon combined stimulation with EGF and crypt growth factors
Authors
Kirsten Ludwig
Edison S Tse
Jean YJ Wang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-221

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine